NEARER SCAN (LENO BESIK) evaluation of a task-sharing echocardiographic active case finding programme for rheumatic heart disease in Australia and Timor-Leste: protocol for a hybrid type II effectiveness-implementation study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 Oct 2024
Historique:
medline: 19 10 2024
pubmed: 19 10 2024
entrez: 18 10 2024
Statut: epublish

Résumé

Rheumatic heart disease (RHD) is underdiagnosed globally resulting in missed treatment opportunities and adverse clinical outcomes. We describe the protocol for a study which aims to co-design, implement and conduct an evaluation of a task-sharing approach to echocardiographic active case finding for early detection and management of RHD in high-risk settings in Australia and Timor-Leste. Echocardiograms will be obtained by trained local staff using hand-held echocardiographic devices employing the 'Single Parasternal Long Axis view with a Sweep of the Heart' (SPLASH) technique and interpreted by experts remote from the site of acquisition. Approximately 1500 children and pregnant women will be screened across high-risk communities in Australia and Timor-Leste over an 18-month period. The study will use a type II effectiveness-implementation hybrid design. A tailored package of implementation strategies will be co-designed with communities and health services and mapped onto a Theory of Change framework. The clinical effectiveness will be assessed as the change in the proportion of the target population that are prescribed secondary prophylaxis for RHD by the end of the study compared with baseline. The implementation will be assessed as the adoption, penetration, sustainability, fidelity and cost of the programme with a mixed-methods theory-based and economic evaluation. Data will include numbers of normal, abnormal and uninterpretable SPLASH echocardiograms obtained, numbers of participants progressing through the cascade of care, interviews with staff and programme costs. Ethical approval has been obtained from the Human Research Ethics Committee of the NT Department of Health and Menzies School of Health Research, Darwin (HREC-2022-4479), the Western Australian Aboriginal Health Ethics Committee (HREC-1237) and the Instituto Nasional Saude Publika Timor-Leste Ethics and Technical Committee (03-UEPD/INSP-TL/V/2023). Informed consent is required to be enrolled. Study findings will be disseminated in the communities involved and submitted for publication. NCT06002243.

Identifiants

pubmed: 39424380
pii: bmjopen-2023-083467
doi: 10.1136/bmjopen-2023-083467
doi:

Banques de données

ClinicalTrials.gov
['NCT06002243']

Types de publication

Journal Article Clinical Trial Protocol

Langues

eng

Sous-ensembles de citation

IM

Pagination

e083467

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Benjamin Jones (B)

Health Systems Collaborative, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

James Marangou (J)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Jennifer Yan (J)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.
Department of Paediatrics, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

Anna Ralph (A)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Alice Mitchell (A)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Alex Kaethner (A)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Bo Remenyi (B)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Department of Paediatrics, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

Vicki Wade (V)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Heart Foundation, Sydney, New South Wales, Australia.

Judith M Katzenellenbogen (JM)

School of Population and Global Health, University of Western Australia, Crawley, Western Australia, Australia.

Anferida Fernandes Monteiro (AF)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Jeffrey W Cannon (JW)

Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia.

Natasha J Howard (NJ)

South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

Marisa Gilles (M)

Western Australia Country Health Service, Perth, Western Australia, Australia.

Emma Haynes (E)

University of Western Australia, Perth, Western Australia, Australia.

Herculano Seixas (H)

Hospital Nacional Guido Valadares, Dili, Timor-Leste.

Joaquina Maurays (J)

Maluk Timor, Dili, Timor-Leste.

Jade Neave (J)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Chantelle Pears (C)

Western Australia Country Health Service, Perth, Western Australia, Australia.

Daniel Engelman (D)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Karla Canuto (K)

Flinders University, Adelaide, South Australia, Australia.

Andrew Steer (A)

Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.

Holger Unger (H)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Meghan Bailey (M)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Maria Tanesi (M)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Salvador Amaral (S)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Helder Neto (H)

Timor-Leste Ministerio da Saude, Dili, Timor-Leste.

Maida Stewart (M)

Miwatj Health Service, Darwin, Northern Territory, Australia.

Paul Burgess (P)

Northern Territory Government of Australia, Darwin, Northern Territory, Australia.

Alex Brown (A)

Indigenous Genomics, Australian National University, Canberra, Australian Capital Territory, Australia.
Telethon Kids Institute, Perth, Western Australia, Australia.

Bart J Currie (BJ)

Department of Infectious Diseases, Royal Darwin Hospital, Casuarina, Northern Territory, Australia.

Graham Hillis (G)

School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.

Peter Morris (P)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

David Simon (D)

Katherine Hospital, Katherine, Northern Territory, Australia.

Gavin Wheaton (G)

Department of Cardiology, Women's and Children's Hospital, Adelaide, South Australia, Australia.

Jacqui Williamson (J)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Jessica de Dassel (J)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Simon Slota-Kan (S)

Western Australia Country Health Service, Perth, Western Australia, Australia.

Jonathan Carapetis (J)

Telethon Kids Institute, Perth, Western Australia, Australia.

Mike English (M)

Health Systems Collaborative, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Shobhana Nagraj (S)

Health Systems Collaborative, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Joshua R Francis (JR)

Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia josh.francis@menzies.edu.au.
Department of Paediatrics, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH